Why do patients choose Italy for transurethral resection of the prostate (TURP)?
Access advanced Transurethral resection of the prostate (TURP) solutions in trusted clinics .
| Italy | Turkey | Austria | |
| Transurethral resection of the prostate (TURP) | - | from $4,100 | from $5,500 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Transurethral resection of the prostate (TURP) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Transurethral resection of the prostate (TURP) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Transurethral resection of the prostate (TURP) journey.
Day 1
Day 2
Day 3
Day 4
Day 5-7
Week 2
Week 3-4
Week 5-6
Week 7
Note: Each patient"s recovery time may vary depending on individual circumstances.
Prof. Montorsi is one of the top Italian experts in Urology and Andrology, with numerous scientific awards and 8,000+ urology/andrology surgeries. He directs the Urological Research Institute (URI) in Italy, is recognized among the most influential researchers of the past decade, and has developed his vein patching method to correct occlusive vein dysfunction. He is an Honorary Fellow of the Royal College of Surgeons of England and has written over 1,000 papers. He is a member of various medical organizations.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.
This prostate surgery involves removing parts of the prostate gland to treat urinary problems due to an enlarged prostate.